GSK329
CAS No. 1268490-12-5
GSK329( GSK-329 | GSK 329 )
Catalog No. M27768 CAS No. 1268490-12-5
GSK329 is an effective and selective inhibitor of TNNI3 Interacting Kinase (TNNI3K). GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 222 | Get Quote |
|
10MG | 356 | Get Quote |
|
25MG | 597 | Get Quote |
|
50MG | 851 | Get Quote |
|
100MG | 1152 | Get Quote |
|
500MG | 2313 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK329
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK329 is an effective and selective inhibitor of TNNI3 Interacting Kinase (TNNI3K). GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury.
-
DescriptionGSK329 is an effective and selective inhibitor of TNNI3 Interacting Kinase (TNNI3K). GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury.
-
In Vitro——
-
In Vivo——
-
SynonymsGSK-329 | GSK 329
-
PathwayOthers
-
TargetOther Targets
-
Recptoramyloid-β| Caspase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1268490-12-5
-
Formula Weight472.25
-
Molecular FormulaC19H14Cl2F3N5O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (211.75 mM)
-
SMILESCNc1cc(Oc2c(Cl)cc(cc2Cl)N(C(N)=O)c2cccc(c2)C(F)(F)F)ncn1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ju Wang, et al. Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer’s disease-related pathologies in a senescence-accelerated mouse model. Translational Neurodegeneration volume 10, Article number: 12 (2021).
molnova catalog
related products
-
Selaginellin
Selaginellin has a neuroprotective effect against L-glutamate-induced neurotoxicity through mechanisms related to anti-oxidation and anti-apoptosis via scavenging reactive oxygen species and up-regulating the expression of klotho gene.
-
Clobetasone butyrate
Clobetasone butyrate can be used to relieve corticosteroid-responsive dermatoses, including atopic?dermatitis and psoriasis.
-
3,8-Di-O-methylellag...
3,3'-Di-O-methylellagic acid reveals moderate antibacterial activity, it also shows strong DPPH radical scavenging activities with SC50 of 123.3 ug/mL.